These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6168129)

  • 1. [Appearance of sulfasalazine and sulfapyridine in breast milk and in the placental barrier as well as the effect of both substances on bilirubin binding to albumin].
    Järnerot G
    Z Gastroenterol Verh; 1981 Jun; 19():27-8. PubMed ID: 6168129
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.
    Esbjörner E; Järnerot G; Wranne L
    Acta Paediatr Scand; 1987 Jan; 76(1):137-42. PubMed ID: 2882643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine.
    Järnerot G; Andersen S; Esbjörner E; Sandström B; Brodersen R
    Scand J Gastroenterol; 1981; 16(8):1049-55. PubMed ID: 6121372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.
    Järnerot G; Into-Malmberg MB; Esbjörner E
    Scand J Gastroenterol; 1981; 16(5):693-7. PubMed ID: 6119765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
    Eitner K; Hippius M; Reinicke C
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished bilirubin binding by the serum of pregnant women.
    Ritter DA; Gabai BR; Kenny JD
    Obstet Gynecol; 1985 May; 65(5):633-6. PubMed ID: 3982740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental and mammary transfer of sulphasalazine.
    Khan AK; Truelove SC
    Br Med J; 1979 Dec; 2(6204):1553. PubMed ID: 43760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
    Eitner K; Reinicke C; Hippius M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
    Sharp ME; Wallace SM; Hindmarsh KW; Brown MA
    Eur J Clin Pharmacol; 1981; 21(3):243-50. PubMed ID: 6119205
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulphasalazine treatment during breast feeding.
    Järnerot G; Into-Malmberg MB
    Scand J Gastroenterol; 1979; 14(7):869-71. PubMed ID: 44005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crohn's disease. Has there been progress in its treatment?].
    Berenguer J
    Med Clin (Barc); 1984 Jun; 83(2):61-4. PubMed ID: 6147447
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of salicylazosulphapyridine and sulphapyridine in plasma using high-performance liquid chromatography.
    Lanbeck K; Lindström B
    J Chromatogr; 1978 Jul; 154(2):321-4. PubMed ID: 28333
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum.
    Murashima A; Watanabe N; Ozawa N; Saito H; Yamaguchi K
    Ann Rheum Dis; 2009 Nov; 68(11):1793-4. PubMed ID: 19822717
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of sulfapyridine and its major metabolites in plasma by high pressure liquid chromatography.
    Fischer C; Klotz U
    J Chromatogr; 1978 Jul; 146(1):157-62. PubMed ID: 27529
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftriaxone effect on bilirubin-albumin binding.
    Fink S; Karp W; Robertson A
    Pediatrics; 1987 Dec; 80(6):873-5. PubMed ID: 3684399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
    Guastavino E; Litwin NH; Heffes Nahmod L; Licastro R
    Acta Gastroenterol Latinoam; 1988; 18(2):107-13. PubMed ID: 2908013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfapyridine metabolites in children with inflammatory bowel disease receiving sulfasalazine.
    Goldstein PD; Alpers DH; Keating JP
    J Pediatr; 1979 Oct; 95(4):638-40. PubMed ID: 39125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of salicylazosulfapyridine (Azulfidine) and metabolites in human breast milk.
    Berlin CM; Yaffe SJ
    Dev Pharmacol Ther; 1980; 1(1):31-9. PubMed ID: 6108198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylazosulfapyridine metabolites in milk.
    Drug Metab Dispos; 1980; 8(3):188-9. PubMed ID: 6104587
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Protein binding of endogenous and exogenous substances in the neonatal period.
    Windorfer A; Pringsheim W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R93. PubMed ID: 1143519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.